| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/02/2009 | US20090170895 S1p3 receptor antagonist |
| 07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170878 Macrocyclic compounds useful as bace inhibitors |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
| 07/02/2009 | US20090170827 Acid Addition Salt of Dihydropyridine Derivative |
| 07/02/2009 | US20090170826 Acid Addition Salt of Optically Active Dihydropyridine Derivative |
| 07/02/2009 | US20090170810 Methods of treatment of cardiovascular and cerebrovascular diseases with low molecular weight fucoidan |
| 07/02/2009 | US20090170801 Methods of treatment of cardiovascular and cerebrovascular diseases with fucoidan |
| 07/02/2009 | US20090170799 Chimeric oligonucleotide for use in diagnosis and treatment of tissue destruction, necrosis and inflammatory diseases |
| 07/02/2009 | US20090170776 Angiogenically effective unit dose of fgf and method of administering |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170757 Methods of using macrocyclic modulators of the ghrelin receptor |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169660 A composition of radix codonopsis and radix astragali, a method for preparation thereof and its application |
| 07/02/2009 | US20090169604 Adhesive Pharmaceutical Preparation Containing Bisoprolol |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169545 5-ht4 receptor antagonists for the treatment of heart failure |
| 07/02/2009 | US20090169544 Formulation |
| 07/02/2009 | US20090169527 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/02/2009 | US20090169521 Vascularized cardiac tissue and methods of producing and using same |
| 07/02/2009 | CA2712414A1 Pharmaceutical composition |
| 07/02/2009 | CA2710791A1 Pyripyropene derivatives having an acat2-inhibiting activity |
| 07/02/2009 | CA2710490A1 Drug delivery system |
| 07/02/2009 | CA2710417A1 Glycosylated glycopeptide antibiotic derivatives |
| 07/02/2009 | CA2709530A1 Monosebacate of pyrazole derivative |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/02/2009 | CA2706372A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075001A1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 07/01/2009 | EP2074127A1 Pyrazolo [1, 5-a]pyrimidine derivatives and their therapeutic use |
| 07/01/2009 | EP2074121A1 Chymase inhibitors |
| 07/01/2009 | EP2074117A2 Heteromonocyclic compound and use thereof |
| 07/01/2009 | EP2074113A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 07/01/2009 | EP2074112A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 07/01/2009 | EP2074108A1 Renin inhibitors |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2074098A2 Quinoline compounds |
| 07/01/2009 | EP2074096A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| 07/01/2009 | EP2073805A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP2073798A2 Pharmaceutical nimodipine compositions |
| 07/01/2009 | EP1838710B1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/01/2009 | EP1784393B1 Quinazolines useful as modulators of ion channels |
| 07/01/2009 | EP1599455B1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1359883A4 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | CN101468984A N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN101467992A Use of L-carnitine for the treatment of cardiovascular diseases |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506807C Amide derivatives as GK activators |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506785C Quaternary ammonium compound, method for production thereof, and therapeutic agent for cerebrovascular disorder and heat disease |
| 07/01/2009 | CN100506293C Coating that promotes endothelial Cell adherence |
| 07/01/2009 | CN100506284C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553870 Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553845 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 06/30/2009 | US7553840 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 06/30/2009 | US7553837 Phenylazole compounds production process and antioxidants |
| 06/30/2009 | US7553823 C-pyrazole A2A receptor agonists |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553482 Preventing atherosclerotic disease, bone disorders by administering iron(III) oxide hydroxide-carbohydrate complexes; for reducing the calcium phosphate product, calcium level in the blood; side effect reduction; controlling blood metal concentration |
| 06/30/2009 | CA2391625C Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan |
| 06/30/2009 | CA2373939C Generation of therapeutic microfoam |
| 06/25/2009 | WO2009079630A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | WO2009079544A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | WO2009079391A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | WO2009078978A2 Compositions containing polyglycidol-based polymers and uses thereof |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 06/25/2009 | WO2009078348A1 Method of producing liquid earthworm extract and method of producing dry earthworm powder |
| 06/25/2009 | WO2009077764A1 Compounds and methods for the treatment of vascular disease |
| 06/25/2009 | WO2009076869A1 Salvianolic acid of high purity, preparation method and use thereof |
| 06/25/2009 | WO2009049961A3 New no-donor aspirin derivatives |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |